Integra Lifesciences Holdings (IART) Gross Profit Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25% |
| Dec 31, 2025 | -1.78% |
| Sep 30, 2025 | -2.54% |
| Jun 30, 2025 | 6.44% |
| Mar 31, 2025 | -2.52% |
| Dec 31, 2024 | 0.28% |
| Sep 30, 2024 | -3.27% |
| Jun 30, 2024 | -1.20% |
| Mar 31, 2024 | -2.17% |
| Dec 31, 2023 | -0.89% |
| Sep 30, 2023 | -0.39% |
| Jun 30, 2023 | -1.97% |
| Mar 31, 2023 | 1.81% |
| Dec 31, 2022 | 2.56% |
| Sep 30, 2022 | 5.98% |
| Jun 30, 2022 | 6.37% |
| Mar 31, 2022 | 6.35% |
| Dec 31, 2021 | 7.92% |
| Sep 30, 2021 | 8.53% |
| Jun 30, 2021 | 8.37% |
| Mar 31, 2021 | 7.11% |
| Dec 31, 2020 | 9.83% |
| Sep 30, 2020 | 10.91% |
| Jun 30, 2020 | 2.20% |
| Mar 31, 2020 | 11.65% |
| Dec 31, 2019 | 12.88% |
| Sep 30, 2019 | 13.85% |
| Jun 30, 2019 | 16.87% |
| Mar 31, 2019 | 18.04% |
| Dec 31, 2018 | 5.13% |
| Sep 30, 2018 | 11.11% |
| Jun 30, 2018 | 13.07% |
| Mar 31, 2018 | 12.71% |
| Dec 31, 2017 | 10.72% |
| Sep 30, 2017 | 6.29% |
| Jun 30, 2017 | 6.79% |
| Mar 31, 2017 | 7.20% |
| Dec 31, 2016 | 7.11% |
| Sep 30, 2016 | 5.44% |
| Jun 30, 2016 | 2.95% |
| Mar 31, 2016 | 1.42% |
| Dec 31, 2015 | 4.24% |
| Sep 30, 2015 | 3.62% |
| Jun 30, 2015 | 3.78% |
| Mar 31, 2015 | 3.07% |
| Dec 31, 2014 | 2.31% |
| Sep 30, 2014 | 2.50% |
| Jun 30, 2014 | 0.77% |